Echosens to Discuss Liver and Metabolic Health at SIIA Conference
News related to:Echosens · 1 min read
WESTBOROUGH, Mass., Oct. 08, 2026 /CourierPR/ -- Echosens, a global leader in non-invasive liver diagnostics, will participate in a panel discussion at the Self-Insurance Institute of America (SIIA) National Conference 2026 in Phoenix. MST.
Shawn McGinnis, Director of Health Systems and Employer Markets at Echosens, will represent the company. The panel aims to explore strategies for managing specialty drug costs, particularly GLP-1 utilization, while addressing employer healthcare needs. McGinnis will discuss how Echosens sees an opportunity to expand the value of obesity and metabolic health investments by increasing visibility into liver health.
According to McGinnis, integrating FibroScan® into on-site and near-site clinics, advanced primary care, and employer screening programs can identify risk earlier, stratify patients, and inform treatment decisions, including the use of GLP-1s and other advanced therapies. Obesity, type 2 diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease (MASLD) frequently overlap. Among patients with MASLD, 82% have obesity, 44% have type 2 diabetes, and 71% have metabolic syndrome, underscoring the connection between liver and metabolic health.
Because MASLD is often asymptomatic, earlier liver assessment is critical, according to Amy Conner, Director of Market Access at Echosens. Point-of-care assessment can identify patients at risk and support more informed metabolic care decisions. FibroScan provides a rapid, non-invasive assessment of liver stiffness and liver fat, with immediate results to support clinical decision-making in primary care and metabolic disease management.
Echosens technology can also be incorporated into existing clinical workflows, supported by onboarding, operator training, and workflow optimization. The company's FibroScan® has significantly changed the practice of liver assessment and is recognized worldwide, validated by more than 5,600 peer-reviewed publications, including nearly 220 international guidelines.